Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Asia Pacific Situational Updates on Generic DAAs – June 2017
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Pricing of Indian generic sofosbuvir, 30th Jan,2016
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Part 2: How is hepatitis C treated?
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Response from CEO, CHAI about the Quick Start program in November 2016